Artiva Biotherapeutics ARTV
NASDAQ ARTV
$7.03 -0.02 (-0.28%)
At close: Sep 29, 2026 · 4:00 PM EDT

Artiva Biotherapeutics (ARTV) Enterprise Value (2024 - 2026)

Updated

Artiva Biotherapeutics (ARTV) recorded Enterprise Value of $32.91 million in Q2 2026, compared with -$105.52 million a year earlier and down 54.5% from the prior quarter.

Analysis

Artiva Biotherapeutics (ARTV) Enterprise Value (2024 - 2026) Analysis & Trends

For FY2025, Artiva Biotherapeutics reported Enterprise Value of -$1.97 million.

  • Across earlier years, Enterprise Value came in at -$71.91 million in FY2024.
  • Quarterly Enterprise Value has ranged from -$105.52 million in Q2 2025 to $92.36 million in Q3 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $72.38 million (Q1 2026), -$1.97 million (Q4 2025) and -$52.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Artiva Biotherapeutics 277.86 Mn 277.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.91 Mn
Mar 31, 2026 72.38 Mn
Dec 31, 2025 -1.97 Mn
Sep 30, 2025 -52.56 Mn
Jun 30, 2025 -105.52 Mn
Mar 31, 2025 -92.91 Mn
Dec 31, 2024 -71.91 Mn
Sep 30, 2024 92.36 Mn
API Access

Artiva Biotherapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ARTV&period=max&api_key=YOUR_API_KEY